Performance of the New Bayer VERSANT HCV RNA 3.0 Assay for Quantitation of Hepatitis C Virus RNA in Plasma and Serum: Conversion to International Units and Comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, Assay

We have evaluated the VERSANT HCV RNA 3.0. Assay (HCV 3.0 bDNA assay) (Bayer Diagnostics, Berkeley, Calif.), which is an improved signal amplification procedure for the HCV 2.0 bDNA assay for the quantitation of hepatitis C virus (HCV) RNA in serum or plasma of HCV-infected individuals. The HCV 3.0...

Full description

Saved in:
Bibliographic Details
Main Authors: Beld, Marcel, Sentjens, Roel, Rebers, Sjoerd, Weegink, Christine, Weel, Jan, Sol, Cees, Boom, René
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2002
Subjects:
Virology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC120248/
https://ncbi.nlm.nih.gov/pubmed/11880394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.40.3.788-793.2002
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items